Skip to main content

Ben Haynor

Stock Analyst at Lake Street

Total Price Targets
6
Stocks Covered
4
Sectors
Healthcare
Most Recent
Feb 18, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • TCMD+62.1%
    Tactile Systems Technology, Inc.
    $23.50 targetOct 3, 2025
  • BFLY+34.1%
    Butterfly Network, Inc.
    $5.50 targetJan 20, 2026
  • TCMD+17.2%
    Tactile Systems Technology, Inc.
    $40.00 targetFeb 18, 2026

Most Bearish

  • TCMD+17.2%
    Tactile Systems Technology, Inc.
    $40.00 targetFeb 18, 2026
  • BFLY+34.1%
    Butterfly Network, Inc.
    $5.50 targetJan 20, 2026
  • TCMD+62.1%
    Tactile Systems Technology, Inc.
    $23.50 targetOct 3, 2025

Stocks Covered by Ben Haynor

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
TCMDTactile Systems Technology, Inc.$40.00$22.85+75.1%2Feb 18, 2026
BFLYButterfly Network, Inc.$5.50$5.37+2.5%2Jan 20, 2026
TMCITreace Medical Concepts, Inc.$14.50$1.84+685.9%1Dec 31, 2024
MYOMyomo, Inc.$3.50$0.90+291.0%1May 20, 2024

Recent Activity

  • Feb 18, 2026— Set$40.00price target onTCMD(Tactile Systems Technology, Inc.)
  • Jan 20, 2026— Set$5.50price target onBFLY(Butterfly Network, Inc.)
  • Oct 3, 2025— Set$23.50price target onTCMD(Tactile Systems Technology, Inc.)
  • Jan 10, 2025— Set$5.00price target onBFLY(Butterfly Network, Inc.)
  • Dec 31, 2024— Set$14.50price target onTMCI(Treace Medical Concepts, Inc.)
  • May 20, 2024— Set$3.50price target onMYO(Myomo, Inc.)

Frequently Asked Questions

Who is Ben Haynor?

Ben Haynor is a stock analyst at Lake Street covering 4 stocks primarily in Healthcare. They have issued 6 price targets since May 20, 2024.

What stocks does Ben Haynor cover?

Ben Haynor currently covers 4 stocks, including TCMD, BFLY, TMCI, MYO.

What is Ben Haynor's latest price target?

Ben Haynor's most recent price target was $40.00 on TCMD (Tactile Systems Technology, Inc.), set on Feb 18, 2026.

What is Ben Haynor's highest price target?

Ben Haynor's highest issued price target is $40.00 on TCMD, set on Feb 18, 2026.

Coverage based on publicly published price targets. Not investment advice.